Search Results - "Culha, Meltem"
-
1
Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis
Published in Drug delivery (31-12-2022)“…Favipiravir, an RNA-dependent RNA polymerase (RdRp) inhibitor, is used to treat patients infected with influenza virus and most recently with SARS-CoV-2…”
Get full text
Journal Article -
2
Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects
Published in Pharmaceutics (01-11-2022)“…Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic…”
Get full text
Journal Article -
3
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial
Published in Pharmaceutics (22-10-2021)“…In COVID-19-induced acute respiratory distress syndrome, the lungs are incapable of filling with sufficient air, leading to hypoxemia that results in high…”
Get full text
Journal Article -
4
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
Published in Journal of pharmaceutical sciences (01-10-2022)“…Coronavirus Disease 2019 (COVID-19) pandemic has been on the agenda of humanity for more than 2 years. In the meantime, the pandemic has caused economic…”
Get more information
Journal Article